TY - STD TI - Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Prim. 2016. https://doi.org/10.1038/nrdp.2016.18. ID - ref1 ER - TY - STD TI - Sia D, Villanueva A, Friedman SL, Llovet JM. Liver Cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017. https://doi.org/10.1053/J.GASTRO.2016.11.048. ID - ref2 ER - TY - STD TI - Pardee AD, Butterfield LH. Immunotherapy of hepatocellular carcinoma. Oncoimmunology. 2012. https://doi.org/10.4161/onci.1.1.18344. ID - ref3 ER - TY - STD TI - Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting Cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014. https://doi.org/10.1158/0008-5472.CAN-14-0155. ID - ref4 ER - TY - STD TI - Ghouri YA, Mian I, Blechacz B. Cancer review: Cholangiocarcinoma. J Carcinog. 2015. https://doi.org/10.4103/1477-3163.151940. ID - ref5 ER - TY - STD TI - Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011. https://doi.org/10.1038/nrgastro.2011.131. ID - ref6 ER - TY - STD TI - El-Serag HB. Hepatocellular Carcinoma. N Engl J Med. 2011. https://doi.org/10.1056/NEJMra1001683. ID - ref7 ER - TY - STD TI - Lubezky N, Facciuto M, Harimoto N, Schwartz ME, Florman SS. Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci. 2015. https://doi.org/10.1002/jhbp.157. ID - ref8 ER - TY - STD TI - Zhang X, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2018. https://doi.org/10.1111/jgh.13843. ID - ref9 ER - TY - STD TI - Showe MK, Kossenkov AV, Showe LC. The peripheral immune response and lung cancer prognosis. Oncoimmunology. 2012. https://doi.org/10.4161/onci.21096. ID - ref10 ER - TY - STD TI - Gustafson MP, Lin Y, LaPlant B, Liwski CJ, Maas ML, League SC, Bauer PR, Abraham RS, Tollefson MK, Kwon ED, Gastineau DA, Dietz AB. Immune monitoring using the predictive power of immune profiles. J Immunother Cancer. 2013. https://doi.org/10.1186/2051-1426-1-7. ID - ref11 ER - TY - STD TI - Buonaguro L, Mauriello A, Cavalluzzo B, Petrizzo A, Tagliamonte M. Immunotherapy in hepatocellular carcinoma. Ann Hepatol. 2019. https://doi.org/10.1016/J.AOHEP.2019.04.003. ID - ref12 ER - TY - STD TI - Connaughton EP, Naicker S, Hanley SA, Slevin SM, Eykelenboom JK, Lowndes NF, O’Brien T, Ceredig R, Griffin MD, Dennedy MC. Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA-DR expression. Immunol Cell Biol. 2018. https://doi.org/10.1111/imcb.12032. ID - ref13 ER - TY - STD TI - Yu M, Zhou X, Niu L, Lin G, Huang J, Zhou W, Gan H, Wang J, Jiang X, Yin B, Li Z. Targeting transmembrane TNF-α suppresses breast cancer growth. Cancer Res. 2013. https://doi.org/10.1158/0008-5472.CAN-12-3946. ID - ref14 ER - TY - JOUR AU - Moritz, T. AU - Niederle, N. AU - Baumann, J. AU - May, D. AU - Kurschel, E. AU - Osieka, R. AU - Kempeni, J. AU - Schlick, E. AU - Schmidt, C. G. PY - 1989 DA - 1989// TI - Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease JO - Cancer Immunol Immunother VL - 29 UR - https://doi.org/10.1007/BF00199290 DO - 10.1007/BF00199290 ID - Moritz1989 ER - TY - STD TI - Jing Y, Sun K, Liu W, Sheng D, Zhao S, Gao L, Wei L. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. Cancer Lett. 2018. https://doi.org/10.1016/j.canlet.2018.07.001. ID - ref16 ER - TY - STD TI - Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JPA, Prasad KR. Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma. World J Surg. 2008. https://doi.org/10.1007/s00268-008-9552-6. ID - ref17 ER - TY - STD TI - Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. PLoS ONE. 2013. https://doi.org/10.1371/journal.pone.0058184. ID - ref18 ER - TY - STD TI - Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, Nelson DR, Cabrera R. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res. 2013. https://doi.org/10.1111/hepr.12019. ID - ref19 ER - TY - STD TI - Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. 2009. https://doi.org/10.1002/hep.22950. ID - ref20 ER - TY - STD TI - Martín-Sierra C, Martins R, Laranjeira P, Abrantes AM, Oliveira RC, Tralhão JG, Botelho MF, Furtado E, Domingues R, Paiva A. Functional impairment of circulating FcεRI + monocytes and myeloid dendritic cells in hepatocellular carcinoma and Cholangiocarcinoma patients. Cytom Part B Clin Cytom. 2019. https://doi.org/10.1002/cyto.b.21777. ID - ref21 ER - TY - STD TI - Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover G, Vizcay-Barrena G, Hedrick CC, Cook HT, Diebold S, Geissmann F. Nr4a1-dependent Ly6Clow monocytes monitor endothelial cells and orchestrate their disposal. Cell. 2013. https://doi.org/10.1016/j.cell.2013.03.010. ID - ref22 ER - TY - STD TI - Hanna RN, Cekic C, Sag D, Tacke R, Thomas GD, Nowyhed H, Herrley E, Rasquinha N, McArdle S, Wu R, Peluso E, Metzger D, Ichinose H, Shaked I, Chodaczek G, Biswas SK, Hedrick CC. Patrolling monocytes control tumor metastasis to the lung. Science. 2015. https://doi.org/10.1126/science.aac9407. ID - ref23 ER - TY - STD TI - Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, Tischendorf JJW, Luedde T, Weiskirchen R, Trautwein C, Tacke F. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One. 2010. https://doi.org/10.1371/journal.pone.0011049. ID - ref24 ER - TY - STD TI - Lopez-Gonzalez JS, Avila-Moreno F, Prado-Garcia H, Aguilar-Cazares D, Mandoki JJ, Meneses-Flores M. Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α. Clin Immunol. 2007. https://doi.org/10.1016/j.clim.2006.11.003. ID - ref25 ER - TY - STD TI - Verronèse E, Delgado A, Valladeau-Guilemond J, Garin G, Guillemaut S, Tredan O, Ray-Coquard I, Bachelot T, N’Kodia A, Bardin-Dit-Courageot C, Rigal C, Pérol D, Caux C, Ménétrier-Caux C. Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. Oncoimmunology. 2016. https://doi.org/10.1080/2162402X.2015.1100791. ID - ref26 ER - TY - STD TI - Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010. https://doi.org/10.1126/science.1178331. ID - ref27 ER - TY - STD TI - Panek CA, Ramos MV, Mejias MP, Abrey-Recalde MJ, Fernandez-Brando RJ, Gori MS, Salamone GV, Palermo MS. Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation. Cell Mol Immunol. 2015. https://doi.org/10.1038/cmi.2014.116. ID - ref28 ER - TY - STD TI - Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011. https://doi.org/10.1038/ICB.2010.158. ID - ref29 ER - TY - STD TI - Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (review). Oncol Lett. 2011. https://doi.org/10.3892/ol.2011.300. ID - ref30 ER - TY - STD TI - Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003. https://doi.org/10.1016/S1359-6101(03)00049-2. ID - ref31 ER - TY - STD TI - Chen K-J, Lin S-Z, Zhou L, Xie H-Y, Zhou W-H, Taki-Eldin A, Zheng S-S. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One. 2011. https://doi.org/10.1371/journal.pone.0024671. ID - ref32 ER - TY - JOUR AU - Liu, J. AU - Farmer, J. D. AU - Lane, W. S. AU - Friedman, J. AU - Weissman, I. AU - Schreiber, S. L. PY - 1991 DA - 1991// TI - Calcineurin is a common target of cyclophilin-cyclosporin a and FKBP-FK506 complexes JO - Cell. VL - 66 UR - https://doi.org/10.1016/0092-8674(91)90124-H DO - 10.1016/0092-8674(91)90124-H ID - Liu1991 ER - TY - STD TI - Pallet N, Fernández-Ramos AA, Loriot M-A. Impact of immunosuppressive drugs on the metabolism of T cells. Int Rev Cell Mol Biol. 2018. https://doi.org/10.1016/bs.ircmb.2018.05.009. ID - ref34 ER - TY - STD TI - Kannegieter NM, Hesselink DA, Dieterich M, Kraaijeveld R, Rowshani AT, Leenen PJM, Baan CC. The effect of Tacrolimus and Mycophenolic acid on CD14+ monocyte activation and function. PLoS One. 2017. https://doi.org/10.1371/journal.pone.0170806. ID - ref35 ER - TY - STD TI - Martín-Sierra C, Martins R, Laranjeira P, Coucelo M, Abrantes AM, Tralhão JG, Botelho MF, Furtado E, Domingues R, Paiva A. Functional and Phenotypic Characterization of Tumor-Infiltrating Leukocyte Subsets and Their Contribution to the Pathogenesis of Hepatocellular Carcinoma and Cholangiocarcinoma. Transl Oncol. 2019. https://doi.org/10.1016/j.tranon.2019.07.019. ID - ref36 ER -